E
Entera Bio Ltd D
D
ENTX
2.10000
USD
-0.09
(-4.11%)
مغلق
حجم التداول
600
الربح لكل سهم
-1
العائد الربحي
-
P/E
-8
حجم السوق
77,347,662
المقالات
العنوان: Entera Bio Ltd
القطاع: Healthcare
الصناعة: Biotechnology
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.